Compensation award — excluded from discretionary-purchase analysis.
Loading…
Traded Nov 3, 2025 · Filed Nov 5, 2025
Synchrony Financial's See remarks sold $221K of Synchrony Financial shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$221,246
Shares × reported transaction price
19 days after results of Oct 15, 2025, 85 days before results of Jan 27, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $74.01 on Nov 3, 2025, within 4% of its 52-week high, after a 2% drop over the previous 30 trading days
52-week range $43.81 (Apr 4, 2025) to $76.86 (Sep 4, 2025), 91% of the way up, from 250 adjusted closes. 30 trading days earlier: $75.58 on Sep 22, 2025. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.3% | +0.3% | +0.1% |
| 30 days | +8.5% | +2.0% | +6.5% |
| 90 days | +2.3% | +2.4% | -0.1% |
| 180 days | +0.3% | +8.0% | -7.7% |
Past results only. Not a forecast.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.